Antinuclear antibodies that seem to be specific to Sjögren’s Syndrome. Their presence is associated with long disease duration, earlier disease onset, parotid gland enlargement, systemic manifestations and also with hypergammaglobulinemia, rheumatoid factors and monoclonal type II cryoglobulins.
Source: PubMed.gov